Author:
Udagawa Hibiki,Ishii Genichiro,Morise Masahiro,Umemura Shigeki,Matsumoto Shingo,Yoh Kiyotaka,Niho Seiji,Ohmatsu Hironobu,Tsuboi Masahiro,Goto Koichi,Ochiai Atsushi,Ohe Yuichiro
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference32 articles.
1. Andersson J, Linderholm B, Bergh J, Elmberger G (2004) HER-2/neu (c-erbB-2) evaluation in primary breast carcinoma by fluorescent in situ hybridization and immunohistochemistry with special focus on intratumor heterogeneity and comparison of invasive and in situ components. Appl Immunohistochem Mol Morphol 12:14–20
2. Bartis D, Mise N, Mahida RY, Eickelberg O, Thickett DR (2013) Epithelial-mesenchymal transition in lung development and disease: does it exist and is it important? Thorax. doi: 10.1136/thoraxjnl-2013-204608
3. Chen Y, Huang Y, Huang Y, Chen J, Wang S, Zhou J (2013) The prognostic value of SOX2 expression in non-small cell lung cancer: a meta-analysis. PLoS ONE 8:e71140. doi: 10.1371/journal.pone.0071140
4. De Marzo AM, Bradshaw C, Sauvageot J, Epstein JI, Miller GJ (1998) CD44 and CD44v6 downregulation in clinical prostatic carcinoma: relation to Gleason grade and cytoarchitecture. Prostate 34:162–168
5. de Melo Maia B et al (2014) EGFR expression in vulvar cancer: clinical implications and tumor heterogeneity. Hum Pathol 45:917–925. doi: 10.1016/j.humpath.2014.01.015
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献